Skip to main content

Errata - English

PDF CSV January 17, 2018 through January 17, 2020 See all Errata for USP–NF How to use
Enter the title of the monograph
Monograph Title Section Source Publication Page Number Errata Official Date Target Errata Print Publication Target Online Fix Publication Description
CYPROHEPTADINE HYDROCHLORIDE ORAL SOLUTION IMPURITIES/Organic Impurities USP42–NF37 1195 1-Jan-2020 NA NA In Standard solution: Change
in Solution B
to:
in Diluent
<857> ULTRAVIOLET-VISIBLE SPECTROSCOPY QUALIFICATION OF UV-VIS SPECTROMETERS Second Supplement to USP42–NF37 9570 1-Jan-2020 NA NA In all instances in Table 4: Change
<
to:

AND
In Control of Photometric Response/Acidic Nicotinic Acid Solutions in 0.1 N Hydrochloric Acid/paragraph 1: Change
Using nicotinic acid solutions, the absorbance… Read More
<121> INSULIN ASSAYS ASSAY/Rabbit Blood Sugar Method—Quantitative Revision Bulletin (Official May 01, 2019) Online 1-Jan-2020 NA NA In Standard stock solution: Change
of USP Insulin RS of the appropriate species
to:
of the USP Insulin Reference Standard of the appropriate species
AND
In Sample stock solution: Change
of USP Insulin RS of the appropriate… Read More
CUPRIC CHLORIDE REAGENTS AND REFERENCE TABLES/Reagent Specifications USP42–NF37 6092 1-Jan-2020 NA NA Change
[7447-39-4].
to:
[10125-13-0].
ZIPRASIDONE CAPSULES PERFORMANCE TESTS/Dissolution <711>/Test 3/Tier 2 Revision Bulletin (Official October 01, 2019) Online 1-Dec-2019 NA NA In Buffer: Change
6.8 g/L g
to:
6.8 g/L
AND
In Standard stock solution 2: Change
Standard stock solution
to:
Standard stock solution 1
SODIUM BICARBONATE IMPURITIES/Carbonate/Analysis USP42–NF37 Online 1-Dec-2019 NA NA Remove the external reference to a reagent in
Sodium Bicarbonate
SIMVASTATIN TABLETS PERFORMANCE TESTS/Dissolution <711> USP42–NF37 4009 1-Dec-2019 NA NA In Standard solution: Change
USP Simvastatin RS in Medium
to:
USP Simvastatin RS in Medium. Transfer a portion of the solution to a centrifuge tube containing about 10 mg of Prewashed manganese dioxide per milliliter of… Read More
ROPINIROLE EXTENDED-RELEASE TABLETS PERFORMANCE TESTS/Dissolution <711> Revision Bulletin (Official July 01, 2019) Online 1-Dec-2019 NA NA In Test 2 and Test 3 in Analysis: Change
Result1 = C1 × (1/L) × (Mr1/Mr2) × 100
to:
Result1 = C1 × V × (1… Read More
MEFENAMIC ACID CAPSULES PERFORMANCE TESTS/Dissolution <711> USP42–NF37 2711 1-Dec-2019 NA NA Change
Solution A, Mobile phase, Standard solution, Sample solution, Chromatographic system, and System suitability: Proceed as directed in the Assay, making any necessary volumetric adjustments.
to:… Read More
AMLODIPINE AND OLMESARTAN MEDOXOMIL TABLETS IMPURITIES/Organic Impurities Second Supplement to USP42–NF37 9101 1-Dec-2019 NA NA In Table 4, Footnote h: Change
0.47,
to:
0.45,
<1430.5> ANALYTICAL METHODOLOGIES BASED ON SCATTERING PHENOMENA—SMALL ANGLE X-RAY SCATTERING AND SMALL ANGLE NEUTRON SCATTERING 6. EXPERIMENTAL CONSIDERATIONS Second Supplement to USP42–NF37 Online 1-Dec-2019 NA NA In 6.2 Resolution/6.2.1 Size resolution: Change
qmin < π/dmax π/dmax
to:
qmin < π/dmax
<1430> ANALYTICAL METHODOLOGIES BASED ON SCATTERING PHENOMENA—GENERAL 1. OVERVIEW: GENERAL CHAPTERS BASED ON SCATTERING PHENOMENA Second Supplement to USP42–NF37 9634 1-Dec-2019 NA NA In Row 6 of Column 4 in Table 1: Change
Also properties of condensated phrases
to:
Also properties of condensated phases
<1227> VALIDATION OF MICROBIAL RECOVERY FROM PHARMACOPEIAL ARTICLES VALIDATION OF NEUTRALIZATION METHODS—RECOVERY COMPARISONS Second Supplement to USP42–NF37 9616 1-Dec-2019 NA NA In paragraph 1 in Recovery on Agar Medium: Change
If it is necessary to solubilize the test stample,
to:
If it is necessary to solubilize the test sample,
25% TETRABUTYLAMMONIUM HYDROXIDE TS REAGENTS AND REFERENCE TABLES/Solutions Second Supplement to USP42–NF37 9336 1-Dec-2019 NA NA Change
Transfer about 34.82 g
to:
Transfer about 77.1 g
0.1 N POTASSIUM HYDROXIDE VS REAGENTS AND REFERENCE TABLES/Solutions USP42–NF37 6185 1-Dec-2019 NA NA Change
Standardization: Add 2 drops of phenolphthalein TS to 20 mL of 0.1 N potassium hydroxide VS. Titrate with 0.1 N hydrochloric acid VS until a permanent pale-pink color is produced.
to:
Standardization: Add 2 drops of… Read More
2,5-DIHYDROXYBENZOIC ACID REAGENTS AND REFERENCE TABLES/Reagent Specifications USP42–NF37 6097 1-Dec-2019 NA NA Change
[303-07-1].
to:
[490-79-9].
HYPROMELLOSE ACETATE SUCCINATE ASSAY USP42–NF37 5772 1-Nov-2019 NA NA In Content of Methoxy and 2-Hydroxypropoxy Groups/Analysis: Change
Result = (rUM/rSM) × (CS/CU) × (Mr1/Mr2)
to:
Read More
GADOTERIDOL Limit of gadoteridol related compound A USP42–NF37 2020 1-Nov-2019 NA NA In Chromatographic system: Change
packing L21
to:
packing L47
<2022> MICROBIOLOGICAL PROCEDURES FOR ABSENCE OF SPECIFIED MICROORGANISMS—NUTRITIONAL AND DIETARY SUPPLEMENTS BUFFER AND MEDIA/Media USP42–NF37 8514 1-Nov-2019 NA NA In Row 5 of Column 2 for L-Cystine in Fluid Selenite–Cystine Medium: Change
10.0 g
to:
10.0 mg
<1229.2> STEAM STERILIZATION OF AQUEOUS LIQUIDS BIOBURDEN/BIOLOGICAL INDICATOR METHOD/Routine Process Control USP42–NF37 8082 1-Nov-2019 NA NA In the first paragraph: Change
calibrartion
to:
calibration
<1228.4> DEPYROGENATION BY RINSING ROUTINE PROCESS CONTROL USP42–NF37 8067 1-Nov-2019 NA NA In the first paragraph: Change
WFI
to:
Water for Injection
<1222> TERMINALLY STERILIZED PHARMACEUTICAL PRODUCTS—PARAMETRIC RELEASE INTRODUCTION USP42–NF37 8021 1-Nov-2019 NA NA In paragraphs 4 and 5: Change
a probability of a PNSU
to:
a PNSU
<55> BIOLOGICAL INDICATORS—RESISTANCE PERFORMANCE TESTS D-VALUE DETERMINATION USP42–NF37 6385 1-Nov-2019 NA NA In the third paragraph in Procedure: Change
stated spore filter
to:
stated spore titer
ZINC SULFATE CHEMICAL INFORMATION USP42–NF37 4649 1-Oct-2019 NA NA Change
Zinc sulfate (1:1) monohydrate 179.46
to:
Zinc sulfate (1:1) monohydrate 179.45
[7446-19-7].
AND
Change
287.56
to:
287.54
TRIFLUOPERAZINE HYDROCHLORIDE TABLETS Assay USP42–NF37 4473 1-Oct-2019 NA NA Change
2(407.51/480.43)C(rU/rS)
to:
2000(407.51/480.43)C(rU/rS)
PENICILLAMINE CAPSULES PERFORMANCE TESTS/Dissolution <711> Revision Bulletin (Official June 11, 2019) Online 1-Oct-2019 NA NA In Procedure for a pooled sample/Analysis: Change
Result = (AU/AS) × (CS/CU) × V × (1/L) × 100
to:
Result = (AU/A… Read More
PAROXETINE HYDROCHLORIDE ADDITIONAL REQUIREMENTS/USP Reference Standards <11> First Supplement to USP42–NF37 8788 1-Oct-2019 NA NA In USP Paroxetine Related Compound G RS: Change
405.46
to:
441.92
HYDROCHLOROTHIAZIDE CAPSULES PERFORMANCE TESTS/Dissolution <711>/Test 2 USP42–NF37 2171 1-Oct-2019 NA NA In Empty capsules solution: Change
Place 10 Capsules
to:
Place 10 empty capsules
DESFLURANE CHEMICAL INFORMATION USP42–NF37 1230 1-Oct-2019 NA NA Change
(±)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
to:
(±)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether;
2-(Difluoromethoxy)-1,1,1,2-tetrafluoroethane.
DESFLURANE ADDITIONAL REQUIREMENTS/USP Reference Standards <11> USP42–NF37 1230 1-Oct-2019 NA NA In USP Desflurane Related Compound A RS: Change
Bis-(1,2,2,2-tetrafluoroethyl)ether.
to:
Bis-(1,2,2,2-tetrafluoroethyl)ether;
Also known as: 1,1,1,2-Tetrafluoro-2-(1,2,2,2-tetrafluoroethoxy)ethane.
BENZALDEHYDE ASSAY/Procedure USP42–NF37 5586 1-Oct-2019 NA NA In Chromatographic system: Delete
Detector temperature: 25°
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION IMPURITIES/Organic Impurities USP42–NF37 487 1-Oct-2019 NA NA In Table 2: Change
Bendamustine related compound B
to:
Bendamustine related compound Ba
AND
Change
Bendamustine related compound Ca
to:
Bendamustine related compound Cb
Read More
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION ADDITIONAL REQUIREMENTS/USP Reference Standards <11> USP42–NF37 487 1-Oct-2019 NA NA In USP Bendamustine Related Compound B RS: Change
4-(1-Methyl-5-morpholino-1H-benzimidazol-2-yl)butanoic acid.
C16H21N3O3 303.36
to:
4-(1-Methyl-5-morpholino-1H-benzimidazol-2-… Read More
ASHWAGANDHA ROOT DRY EXTRACT COMPOSITION/Content of Withanolides USP42–NF37 4724 1-Oct-2019 NA NA In the first equation in Analysis: Change
CS = concentration of USP Withanoside IV RS in Standard solution A (mg/mL)
to:
CS = concentration of USP Withanolide A RS in Standard solution A… Read More
ANAGRELIDE CAPSULES PERFORMANCE TESTS/Dissolution <711>/Analysis USP42–NF37 329 1-Oct-2019 NA NA Change
Result = (rU/rS) x (CS/CU) x (Mr1/Mr2) x (V/L) x 100
to:
Result = (rU/rS Read More
AMIODARONE HYDROCHLORIDE CHEMICAL INFORMATION USP42–NF37 253 1-Oct-2019 NA NA See https://www.uspnf.com/sites/default/files/usp_pdf/EN/september-2019-errata-with-image.pdf for correction.
SILDENAFIL CITRATE ADDITIONAL REQUIREMENTS/USP Reference Standards <11> USP42–NF37 4002 1-Sep-2019 NA NA In USP Sildenafil Related Compound A RS: Change
5-[2-Ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2-methylpropyl)-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one.
C23H32N6O4S… Read More
OLMESARTAN MEDOXOMIL TABLETS IMPURITIES/Organic Impurities Revision Bulletin (Official March 19, 2019) Online 1-Sep-2019 NA NA In the Analysis: Change
CS = concentration of in the Standard solution (mg/mL)
to:
CS = concentration of USP Olmesartan Medoxomil RS in the Standard solution (mg/mL)
MORPHINE SULFATE EXTENDED-RELEASE CAPSULES IMPURITIES/Organic Impurities USP42–NF37 Online 1-Sep-2019 NA NA Change
Diluent, Solution A, System suitability solution, Chromatographic system, and Sample solution: Proceed as directed in the Assay.
to:
Diluent, Buffer solution, Solution A,… Read More
MECLOFENAMATE SODIUM CHEMICAL INFORMATION USP42–NF37 2706 1-Sep-2019 NA NA Change
336.15
to:
336.14
AND
Change
[6385-02-0];
to:
[67254-91-5];
AND
Change
UNII: 9MMQ0YER4E.
to:
UNII: 94NJ818U2W.
LEVOFLOXACIN CHEMICAL INFORMATION USP42–NF37 2552 1-Sep-2019 NA NA Change
Anhydrous [100986-85-41].
to:
Anhydrous [100986-85-4].
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS ADDITIONAL REQUIREMENTS/USP Reference Standards <11> Revision Bulletin (Official August 01, 2018) Online 1-Sep-2019 NA NA In USP Fexofenadine Related Compound A RS: Change
Benzeneacetic acid, 4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl.
to:
2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl)-2-methylpropanoic acid;
Also known as… Read More
FEXOFENADINE HYDROCHLORIDE TABLETS ADDITIONAL REQUIREMENTS/USP Reference Standards <11> Revision Bulletin (Official November 01, 2018) Online 1-Sep-2019 NA NA In USP Fexofenadine Related Compound A RS: Change
Benzeneacetic acid, 4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl.
to:
2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl)-2-methylpropanoic acid;
Also known as… Read More
FEXOFENADINE HYDROCHLORIDE CAPSULES ADDITIONAL REQUIREMENTS/USP Reference Standards <11> USP42–NF37 1830 1-Sep-2019 NA NA In USP Fexofenadine Related Compound A RS: Change
Benzeneacetic acid, 4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl.
C32H37NO4 538.12
to:
2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]… Read More
FEXOFENADINE HYDROCHLORIDE ADDITIONAL REQUIREMENTS/USP Reference Standards <11> USP42–NF37 1828 1-Sep-2019 NA NA In USP Fexofenadine Related Compound A RS: Change
Benzeneacetic acid, 4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl.
to:
2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl)-2-methylpropanoic acid;
Also known as… Read More
CIDOFOVIR INJECTION IMPURITIES/Organic Impurities USP42–NF37 981 1-Sep-2019 NA NA In Table 1: Change
0.56
to:
0.59
CHLOROQUINE PHOSPHATE ADDITIONAL REQUIREMENTS/USP Reference Standards <11> USP42–NF37 939 1-Sep-2019 NA NA In USP Chloroquine Related Compound G RS: Change
C18H26Cl3NO · H2SO4
to:
C18H26ClN3O · H2SO4
CALCIUM CARBONATE IMPURITIES/Limit of Magnesium and Alkali Salts USP42–NF37 666 1-Sep-2019 NA NA Change
Sample solution: 1.0 g
to:
Sample: 1.0 g
<1160> PHARMACEUTICAL CALCULATIONS IN PHARMACY PRACTICE 19. MEAN KINETIC TEMPERATURE USP42–NF37 7831 1-Sep-2019 NA NA In 19.4 Example Calculations of MKT for CRT Storage Evaluation/Example 3—Calculation of Annual MKTStep 3: Change
3.354
to:
3.340
AND
In Step 4: Change
2.795
to:
2.783
AND
In Step 5… Read More
VALGANCICLOVIR HYDROCHLORIDE Related compounds USP42–NF37 4528 1-Aug-2019 NA NA In Column 2 of Table 3: Change
Bis-valine easter of ganciclovir
to:
Bis-valine ester of ganciclovir